ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 77 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $5,084,000 | -34.8% | 75,000 | -32.3% | 0.74% | -29.7% |
Q4 2016 | $7,793,000 | -0.9% | 110,842 | 0.0% | 1.05% | +21.1% |
Q3 2016 | $7,863,000 | +45.0% | 110,842 | 0.0% | 0.87% | +12.7% |
Q2 2016 | $5,421,000 | -21.8% | 110,842 | +1.2% | 0.77% | -26.3% |
Q1 2016 | $6,932,000 | -43.6% | 109,500 | 0.0% | 1.04% | -29.0% |
Q4 2015 | $12,284,000 | +16.5% | 109,500 | 0.0% | 1.47% | -12.7% |
Q3 2015 | $10,546,000 | +1.0% | 109,500 | +7.4% | 1.68% | +21.2% |
Q2 2015 | $10,444,000 | +64.9% | 102,000 | 0.0% | 1.39% | +41.9% |
Q1 2015 | $6,333,000 | +20.3% | 102,000 | -15.0% | 0.98% | +20.6% |
Q4 2014 | $5,266,000 | -22.5% | 120,000 | 0.0% | 0.81% | -41.9% |
Q3 2014 | $6,792,000 | +26.1% | 120,000 | 0.0% | 1.40% | -2.1% |
Q2 2014 | $5,387,000 | +83.7% | 120,000 | +100.0% | 1.43% | +111.7% |
Q1 2014 | $2,933,000 | – | 60,000 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |